期刊文献+

肠屏障功能与肠外营养相关肝损伤关系研究进展 被引量:4

Relationship between intestinal barrierfunction and parenteral nutritionassociated liver disease
下载PDF
导出
摘要 肠外营养(PN)为不能经肠内喂养获得充足营养物质的病人提供了营养支持,在临床应用中至关重要。但长期PN的病人会出现如导管相关血流感染、肝功能受损等诸多并发症,其发生机制的根源之一是PN引起的肠屏障功能损伤。近年来相关研究众多,本文对PN引起肠屏障功能受损的机制及其在肠外营养相关肝损伤(PNALD)发生发展中的作用做一综述。 Parenteral nutrition(PN)isalifesaving method for adults or children who cannot be provided with sufficient nutrients enterally,and is crucial in clinical practice.However,long-term PN may lead to many complications such as catheter-related bloodstream infectionsand impaired liver function.It is considered that intestinal barrier dysfunction caused by PN is one of the majormechanisms involved in these complications.There have been many studies recently in such field.This paper reviewed the mechanism of intestinal barrier dysfunction caused by PN and its role in the development of parenteral nutrition-associated liver disease(PNALD).
作者 刘坤慧 颜伟慧 蔡威 LIU Kun-hui;YAN Wei-hui;CAI Wei(Department of Pediatric Surgery,Xinhua Hospital,Shanghai Jiaotong University Medical School,Shanghai 200092,China)
出处 《肠外与肠内营养》 CAS CSCD 北大核心 2022年第6期370-374,共5页 Parenteral & Enteral Nutrition
基金 上海市卫生系统重要薄弱学科建设(2019ZB0101) 上海市临床重点专科建设项目(shslczdzk05702) 上海市科委基于长三角同质化小儿消化道畸形防治体系研究(19495810500) 上海申康医院发展中心临床创新三年行动计划资助(SHDC2020CR2010A)
关键词 肠外营养 肠外营养相关性肝损伤 肠屏障功能 肠上皮细胞 肠道菌群 Parenteral nutrition Parenteral nutrition-associated liver disease Intestinal barrier Intestinal epithelial cell Intestinal microbiota
  • 相关文献

参考文献2

二级参考文献32

  • 1Ol(eefe SJ, Buchman AL, Fishbein TM, et al. Short bowel syn- drome and intestinal failure:consensus definitions and overview. Clin Gastroenterol Hepato1,2006,4 ( 1 ) :6-10. 被引量:1
  • 2Le HD, Fallon EM, Meijer VE, et al. Innovative parenteral and enteral nutrition therapy for intestinal failure. Semin Pediatr Surg, 2010,19( 1 ) :27-34. 被引量:1
  • 3Cowan E, Nandivada P, Puder M. Fish oil-based lipid emulsion in the treatment of parenteral nutrition-associated liver disease. Cur- rent Opinion in Pediatrics,2013,25 (2) : 193-200. 被引量:1
  • 4Kelly DA. Intestinal failure-associated liver disease:what do we know today ? Gastroenterology,2006,130 ( 2 Suppl 1 ) : S70 -S77. 被引量:1
  • 5Premkumar MH, Caner BA, Hawthorne KM, et al. High rates of resolution of cholestasis in parenteral nutrition-associated liver disease with fish oil-based lipid emulsion monotherapy. J Pediatr, 2013,162(4) :793-798. 被引量:1
  • 6Bharadwaj S, Gohel T, Deen O J, et al. Fish oil-based lipid emul- sion: current updates on a promising novel therapy for the man- agement of parenteral nutrition-associated liver disease. Gastroen- terol Rep (Oxf) ,2015,3(2) :110-114. 被引量:1
  • 7Nandivada P, Carlson S J, Chang MI, et al. Treatment of parenteral nutrition-associated liver disease : the role of lipid emulsions. Adv Nutr,2013,4(6) :711-717. 被引量:1
  • 8Eloranta JJ, Kullak UGA. The role of FXR in disorders of bile acid homeostasis. Physiology ( Bethesda ), 2008,23 ( 5 ) : 286- 295. 被引量:1
  • 9Calder PC. Immunomodulation by omega-3 fatty acids. Prostaglan- dins, Leukotrienes and Essential Fatty Acids, 2007,77 ( 5-6 ) : 327-335. 被引量:1
  • 10Node K, Huo Y, Ruan X, et al. Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science, 1999,285 (5431) :1276-1279. 被引量:1

共引文献14

同被引文献50

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部